IGFBP5 | Insulin-like growth factor binding protein 5 | Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
IGSF10 | Immunoglobulin superfamily, member 10 | Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
INHA | Inhibin, alpha | Predicted secreted proteins
| | | | | Tissue enhanced |
IRS4 | Insulin receptor substrate 4 | Predicted secreted proteins
| | | | | Tissue enhanced |
KCNMB2 | Potassium large conductance calcium-activated channel, subfamily M, beta member 2 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
KCNT2 | Potassium channel, subfamily T, member 2 | Predicted intracellular proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enhanced |
KLF15 | Kruppel-like factor 15 | Disease related genes Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
LAMP5 | Lysosomal-associated membrane protein family, member 5 | Predicted membrane proteins
| | | | | Tissue enhanced |
LPAR4 | Lysophosphatidic acid receptor 4 | G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
LRRC17 | Leucine rich repeat containing 17 | Predicted secreted proteins
| | | | | Tissue enhanced |
MCC | Mutated in colorectal cancers | Predicted intracellular proteins
| | | | | Tissue enhanced |
MEX3A | Mex-3 RNA binding family member A | Predicted intracellular proteins
| | | | | Tissue enhanced |
MKX | Mohawk homeobox | Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
MMP21 | Matrix metallopeptidase 21 | Enzymes FDA approved drug targets Predicted secreted proteins
| | | | | Tissue enhanced |
NAV3 | Neuron navigator 3 | Cancer-related genes Disease related genes Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
NDP | Norrie disease (pseudoglioma) | Disease related genes Predicted secreted proteins
| | | | | Tissue enhanced |
NDST4 | N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 4 | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
NGF | Nerve growth factor (beta polypeptide) | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enhanced |
NLGN4X | Neuroligin 4, X-linked | Disease related genes Predicted membrane proteins
| | | | | Tissue enhanced |
NR2F2 | Nuclear receptor subfamily 2, group F, member 2 | Disease related genes Nuclear receptors Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
NRG2 | Neuregulin 2 | Cancer-related genes Predicted membrane proteins
| | | | | Tissue enhanced |
NRK | Nik related kinase | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
NTF3 | Neurotrophin 3 | Cancer-related genes Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
NYNRIN | NYN domain and retroviral integrase containing | Predicted intracellular proteins
| | | | | Tissue enhanced |
OXTR | Oxytocin receptor | FDA approved drug targets G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
PABPC5 | Poly(A) binding protein, cytoplasmic 5 | Predicted intracellular proteins
| | | | | Tissue enhanced |
PCDH11X | Protocadherin 11 X-linked | Predicted membrane proteins
| | | | | Tissue enhanced |
PDGFRA | Platelet-derived growth factor receptor, alpha polypeptide | Cancer-related genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enhanced |
PEG3 | Paternally expressed 3 | Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
PLCXD3 | Phosphatidylinositol-specific phospholipase C, X domain containing 3 | Predicted intracellular proteins
| | | | | Tissue enhanced |
PLIN5 | Perilipin 5 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
PRSS35 | Protease, serine, 35 | Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |
RASGRF2 | Ras protein-specific guanine nucleotide-releasing factor 2 | Predicted intracellular proteins RAS pathway related proteins
| | | | | Tissue enhanced |
RASL11B | RAS-like, family 11, member B | Predicted intracellular proteins
| | | | | Tissue enhanced |
RP1-66C13.4 | Uncharacterized protein {ECO:0000313|Ensembl:ENSP00000462879} | Predicted intracellular proteins
| | | | | Tissue enhanced |
RP6-24A23.6 | Uncharacterized protein {ECO:0000313|Ensembl:ENSP00000457111} | Predicted intracellular proteins
| | | | | Tissue enhanced |
SCN7A | Sodium channel, voltage-gated, type VII, alpha subunit | Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
SCUBE1 | Signal peptide, CUB domain, EGF-like 1 | Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
SERHL2 | Serine hydrolase-like 2 | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
SLC4A3 | Solute carrier family 4 (anion exchanger), member 3 | Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SNCAIP | Synuclein, alpha interacting protein | Disease related genes Predicted intracellular proteins
| | | | | Tissue enhanced |
STATH | Statherin | Plasma proteins Predicted secreted proteins Transporters
| | | | | Tissue enhanced |
STXBP5L | Syntaxin binding protein 5-like | Predicted intracellular proteins
| | | | | Tissue enhanced |
SUSD4 | Sushi domain containing 4 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
SYTL4 | Synaptotagmin-like 4 | Predicted intracellular proteins
| | | | | Tissue enhanced |
TCF23 | Transcription factor 23 | Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
TENM4 | Teneurin transmembrane protein 4 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
TLR5 | Toll-like receptor 5 | Disease related genes Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
TMEM221 | Transmembrane protein 221 | Predicted membrane proteins
| | | | | Tissue enhanced |
TMEM255A | Transmembrane protein 255A | Predicted membrane proteins
| | | | | Tissue enhanced |